Stay updated on IRX-2 Combo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Combo in Gastric Cancer Clinical Trial page.

Latest updates to the IRX-2 Combo in Gastric Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4; this appears to be a minor site version update with no visible changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedConsolidated the Locations section to display Arizona, California, and Texas (Revision: v3.3.3). Removed the separate Arizona Locations, California Locations, and Texas Locations entries, and removed the HHS Vulnerability Disclosure link.SummaryDifference0.4%

- Check55 days agoChange DetectedA revision label in the page footer updated from v3.2.0 to v3.3.2; this is a minor UI update that does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRemoved a government funding operating-status notice that previously appeared on the page. The notice informed users about potential updates and NIH operations; its removal does not impact the study details or functionality of this page.SummaryDifference0.4%

- Check76 days agoChange DetectedAdded a Results section with posted results dates and outcome measures (e.g., PFS and OS).SummaryDifference0.4%

- Check105 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

Stay in the know with updates to IRX-2 Combo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Combo in Gastric Cancer Clinical Trial page.